(Q41734045)

8 October 2017

1 reference

title

Posttransplant medical complications (English)

1 reference

8 October 2017

Rao VK

1

1 reference

8 October 2017

1 February 1998

1 reference

Surgical Clinics of North America

8 October 2017

1 reference

8 October 2017

78

1 reference

8 October 2017

1

1 reference

8 October 2017

113-132

1 reference

Renal transplantation and skin diseases: review of the literature and results of a 5-year follow-up of 285 patients

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Transplant renal artery stenosis: experience and comparative results between surgery and angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Hodgkin's disease following solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Benefits of removal of native kidneys in hypertension after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Ocular Complications in Renal Allograft Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Reversal of aluminum-related bone disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Renal transplantation: recurrence of original disease with particular reference to primary glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Improvement of cadaver renal transplantation outcomes with verapamil: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Open heart operations after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Malignant tumours after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Is chronic renal transplant rejection a non-immunological phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Renovascular hypertension after renal transplantation - don't look only after the graft artery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Long-term outlook for renal transplant recipients with one-year function. "Doctor, what are my chances"?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Erythrocytosis after renal transplantation; treatment by removal of the native kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Posttransplant erythrocytosis: an enigma revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Malignant disease in patients with long-term renal transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Factors influencing early renal function in cadaver kidney transplants. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Tubular dysfunction following kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Plasma exchange in chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Musculoskeletal Complications After Renal Transplantation: Pathogenesis and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Complete regression of recurrent diffuse malignant lymphoma after withdrawal of cyclosporin A in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

The variable nature of chronic declines in renal allograft function

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Histopathologic findings associated with a chronic, progressive decline in renal allograft function

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

The adverse impact of cyclosporine on serum lipids in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Lovastatin treatment of hypercholesterolemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Increased Prevalence of Dysplastic and Malignant Lip Lesions in Renal-Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Effects of nicotinic acid and lovastatin in renal transplant patients: a prospective, randomized, open-labeled crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Post-transplant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Plasma exchange in the treatment of early recurrent focal glomerulosclerosis after renal transplantation. Report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Cold lymphocytotoxins: an important cause of acute tubular necrosis occurring immediately after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Ischemia, injury, and renal allograft rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Prevalence and clinical spectrum of skin diseases in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Postrenal transplant erythrocytosis: further evidence implicating erythropoietin production by the native kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Progression of kidney disease in chronic renal transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Hyperlipidemia in renal transplant recipients: natural history and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Immunological and hemodynamic mechanisms in chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Hepatitis C virus infection in dialysis and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Recurrent diseases in the kidney transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

The impact of diabetes on vascular complications following cadaver renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Hemosiderosis and hemochromatosis in renal transplant recipients. Clinical and pathological features, diagnostic correlations, predisposing factors, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Liver disease after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Acute graft rejection in the late survivors of renal transplantation. Clinical and histological observations in the second decade

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Post Transplant Acute Renal Failure: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Thromboembolic disease in renal allograft recipients. What is its clinical significance?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Peptic ulcer disease following renal transplantation in the cyclosporine era

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

The detrimental effects of delayed graft function in cadaver donor renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Captopril renography and the hypertensive renal transplantation patient: a predictive test of therapeutic outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Acute leukaemia following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Vascular complications in renal allografts: detection with duplex Doppler US

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Effects of initial ischemia/reperfusion injury on the transplanted kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Favorable effects of fish oil concentrate on risk factors for thrombosis in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Hypertension after renal transplantation. Calcium channel or converting enzyme blockade?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Treatment of severe nephrotic syndrome with meclofenamate: an uncontrolled pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Lipid and lipoprotein (a) concentrations in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970638-1

7 January 2021

10.1016/S0039-6109(05)70638-1

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9531939